Skip to content
Clinical Trials – home

Meropenem Trihydrate: A Powerful Antibiotic for Serious Infections

6 / 6
trials open to patients / all trials
6+
Countries

In short

Meropenem Trihydrate, a powerful antibiotic, is currently being studied in various clinical trials to assess its effectiveness in treating severe infections. These trials aim to evaluate the drug's potential in conditions such as infectious endocarditis, sepsis, and critically ill patients in intensive care units. The research focuses on optimizing dosing strategies, comparing Meropenem to other antibiotics, and assessing its impact on patient outcomes.

At a glance

Drug Name
Meropenem Trihydrate
Administration Method
Intravenous injection or infusion
Conditions Studied
Infectious endocarditis, Sepsis, Critical illnesses in ICU
Main Objectives
Evaluate safety and efficacy, Compare with other antibiotics, Optimize dosing strategies
Key Outcomes Measured
Mortality rates, Length of hospital stay, Antibiotic treatment duration, Complications, Quality of life
Patient Groups
Adults with specific severe infections, Critically ill patients in ICU
Dosage Range
Varies by trial, up to 6g daily
Treatment Duration
Varies by trial, ranging from 3 days to 6 weeks

What is Meropenem Trihydrate?

Meropenem Trihydrate is a powerful antibiotic medication used to treat serious bacterial infections. It belongs to a class of antibiotics called carbapenems, which are known for their broad-spectrum activity against many types of bacteria. Meropenem works by interfering with the formation of the bacterial cell wall, ultimately leading to the death of the bacteria.

Medical Conditions Treated with Meropenem

Meropenem is used to treat various severe infections, including:

  • Infectious endocarditis: An infection of the inner lining of the heart chambers and valves.
  • Sepsis: A life-threatening condition that occurs when the body's response to infection causes widespread inflammation and organ failure.
  • Septic shock: A severe form of sepsis that causes a dangerous drop in blood pressure.

These conditions are often caused by bacteria such as Staphylococcus aureus, Enterococcus faecalis, and various streptococci species.

How is Meropenem Administered?

Meropenem is typically given as an intravenous (IV) injection or infusion. This means it is delivered directly into the bloodstream through a vein. The medication is usually administered in a hospital setting, especially for patients who are critically ill or in the intensive care unit (ICU).

Dosage Information

The dosage of Meropenem can vary depending on the severity of the infection and the patient's condition. Some general dosage information includes:

  • For adults, the maximum daily dose is typically 6 grams (g).
  • The duration of treatment can range from a few days to several weeks, depending on the infection being treated.
  • In some cases, continuous infusion of the antibiotic may be used instead of intermittent doses.

It's important to note that the exact dosage and duration of treatment should always be determined by a healthcare professional based on the individual patient's needs and response to the medication.

Current Clinical Studies

Several ongoing clinical trials are investigating the use of Meropenem in various scenarios:

  1. Accelerated treatment of infectious endocarditis: This study is examining whether a shorter course of antibiotic treatment, including Meropenem, can be safe and effective for patients with left-sided heart infections.
  2. Comparison with Piperacillin/Tazobactam in sepsis: The EMPRESS trial is comparing Meropenem to another antibiotic combination (Piperacillin/Tazobactam) in critically ill adults with sepsis to assess effects on mortality and other important outcomes.
  3. Optimizing initial dosing in critically ill patients: The BuLLSEYE study is investigating whether a new dosing strategy for antibiotics like Meropenem can improve clinical outcomes for sepsis patients in the ICU.

These studies aim to refine the use of Meropenem and potentially improve treatment outcomes for patients with severe infections.

Potential Side Effects and Precautions

While Meropenem is generally well-tolerated, it can cause side effects in some patients. Potential side effects may include:

  • Allergic reactions (including anaphylaxis in rare cases)
  • Gastrointestinal issues (such as diarrhea)
  • Skin reactions (in rare cases)

Precautions should be taken in certain situations:

  • Patients with known allergies to beta-lactam antibiotics should not use Meropenem.
  • Caution is advised in patients with a history of seizures, as Meropenem may increase the risk of seizures in some cases.
  • Patients taking valproic acid (an anti-seizure medication) should be aware of potential interactions with Meropenem.

It's crucial to inform your healthcare provider about any medical conditions, allergies, or medications you're taking before starting treatment with Meropenem.

Questions people often ask

Conditions where Meropenem Trihydrate is being studied

Each condition opens its own overview and trial list

Trials with Meropenem Trihydrate

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Children
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.